Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 79931 

to be re-applied to another cover sheet 

or invoice (transfer of funds). 

The electronic user fee payment 

request forms streamline the refund and 

transfer processes, facilitate processing, 

and improve the tracking of refund or 

transfer requests. The burden for this 

collection of information is the same for 

all customers (small and large 

organizations). The information being 

requested or required has been held to 

the absolute minimum required for the 

intended use of the data. Respondents 

are able to request a user fee payment 

refund or transfer online at https://

www.fda.gov/forindustry/userfees/ 

default.htm. This electronic submission 

is intended to reduce the burden for 

customers to submit a user fee payment 

refund and transfer request. 

In the Federal Register of April 26, 

2024 (89 FR 32445), FDA published a 

60-day notice requesting public 

comment on the proposed collection of 

information. No comments were 

received. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN1 2

FDA form No. No. of 

respondents 

No. of 

responses per 

respondent 

Total annual 

responses 

Average burden per 

response Total hours 

User Fee Payment Refund Request—Form FDA 

3913.

1,856 1 1,856 0.40 (24 minutes) .......... 742 

User Fee Payment Transfer Request—Form 

FDA 3914.

86 1 86 0.25 (15 minutes) .......... 22 

Total .............................................................. ........................ ........................ ........................ ....................................... 764 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

2 Numbers have been rounded. 

Our estimated burden for the 

information collection reflects an 

overall increase of 525 hours and a 

corresponding increase of 1,274 

responses. We attribute this adjustment 

to an increase in the number of 

submissions we received over the last 

few years. 

Dated: September 25, 2024. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2024–22443 Filed 9–30–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of Solicitation of 

Written Comments on Proposed 

Healthy People 2030 Objectives 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary of 

Health, Office of Disease Prevention and 

Health Promotion. 

ACTION: Notice. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

solicits written comments from the 

public on 12 new objectives proposed to 

be added to Healthy People 2030, and 

written comments from the public 

proposing additional new core, 

developmental, or research objectives or 

topics to be included in Healthy People 

2030. Public comment informed the 

development of Healthy People 2030. 

HHS will provide opportunities for 

public input periodically throughout the 

decade to ensure Healthy People 2030 

reflects current public health priorities 

and public input. The updated set of 

Healthy People 2030 objectives and 

topics will be incorporated on https://

health.gov/healthypeople. This updated 

set will reflect further review and 

deliberation by federal Healthy People 

topic area workgroups, the Federal 

Interagency Workgroup on Healthy 

People 2030, and other federal subject 

matter experts. 

DATES: Written comments will be 

accepted through 11:59 p.m. ET, 

October 31, 2024. 

ADDRESSES: Written comments should 

be submitted by email to 

HP2030Comment@hhs.gov. 

FOR FURTHER INFORMATION CONTACT: Erik 

Orta, Office of Disease Prevention and 

Health Promotion, U.S. Department of 

Health and Human Services, 1101 

Wootton Parkway, Suite 420, Rockville, 

MD 20852; Phone: 240–268–0823; 

Email: HP2030@hhs.gov. 

SUPPLEMENTARY INFORMATION: Since 

1980, Healthy People has provided a 

comprehensive set of national health 

promotion and disease prevention 

objectives with 10-year targets aimed at 

improving the health of all. Healthy 

People 2030 objectives present a picture 

of the nation’s health at the beginning 

of the decade, establish national goals 

and targets to be achieved by the year 

2030, and monitor progress over time. 

The U.S. Department of Health and 

Human Services (HHS) is soliciting the 

submission of written comments 

regarding 12 new objectives proposed to 

be added to the current set of Healthy 

People 2030 objectives. The public is 

also invited to submit proposals for 

additional new core, developmental, or 

research objectives that meet the criteria 

outlined below. 

Healthy People 2030 is the product of 

an extensive collaborative process that 

relies on input from a diverse array of 

individuals and organizations, both 

within and outside the federal 

government, with a common interest in 

improving the nation’s health. Public 

comments were a cornerstone of 

Healthy People 2030’s development. 

During the first phase of planning for 

Healthy People 2030, HHS asked for the 

public’s comments on the initiative’s 

vision, mission, and overarching goals. 

Those comments helped set the 

framework for Healthy People 2030. The 

public was also invited to submit 

comments on proposed Healthy People 

2030 objectives, which helped shape the 

current set of Healthy People 2030 

objectives. 

The public now is invited to comment 

on 12 new objectives proposed to be 

added to Healthy People 2030. These 

new objectives were developed by 

Healthy People topic area workgroups 

led by various agencies within the 

Federal Government. They have been 

reviewed by the Federal Interagency 

Workgroup on Healthy People 2030 and 

are presented now for the public’s 

review and comment. They are: 

1. CKD–NEW–11: Increase the 

proportion of people with chronic 

kidney disease and diabetes who receive 

glucose-lowering medications based on 

the most recent guidelines. This 

objective is new to Healthy People 2030. 

Data source: National Health and 

Nutrition Examination Survey 

(NHANES). 


khammond on DSKJM1Z7X2PROD with NOTICES
79932 Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 

2. CKD–NEW–12: Increase the 

proportion of people with chronic 

kidney disease and severe albuminuria 

who receive glucose-lowering 

medications based on the most recent 

guidelines. Data source: National Health 

and Nutrition Examination Survey 

(NHANES). 

3. ECBP–NEW–02: Increase the 

proportion of medical schools that 

include environmental health content in 

a required learning experience. Data 

source: American Association of 

Colleges of Osteopathic Medicine 

(AACOM) and Association of American 

Medical Colleges (AAMC) (2022 Annual 

Osteopathic Medical School 

Questionnaire and Liaison Committee 

on Medical Education (LCME); Annual 

Medical School Questionnaire Part II). 

4. ECBP–NEW–03: Increase the 

proportion of undergraduate nursing 

and graduate nurse practitioner training 

programs that include environmental 

health content in a required learning 

experience. Data source: American 

Association of Colleges of Nursing 

(AACN) and National Organization of 

Nurse Practitioner Faculties (NONPF) 

(2022 American Association of Colleges 

of Nursing Healthy People 2030 

Curriculum Survey; 2022 National 

Organization of Nurse Practitioner 

Faculties Healthy People 2030 

Curriculum Survey). 

5. ECBP–NEW–04: Increase the 

proportion of physician assistant (PA) 

training programs that include 

environmental health content in a 

required learning experience. Data 

source: Physician Assistant Education 

Association (PAEA) (2022 Physician 

Assistant Education Association 

Healthy People 2030 Survey). 

6. ECBP–NEW–05: Increase the 

proportion of colleges and schools of 

pharmacy with Doctor of Pharmacy 

(PharmD) degree programs that include 

environmental health content in a 

required learning experience. Data 

source: American Association of 

Colleges of Pharmacy (AACP) (2022 

American Association of Colleges and 

Pharmacy Healthy People 2030 Survey). 

7. ECBP–NEW–06: Increase the 

proportion of colleges and schools of 

dentistry with Doctor of Dental Surgery 

(DDS) and/or Doctor of Dental Medicine 

(DMD) degree programs that include 

environmental health content in a 

required learning experience. Data 

source: American Dental Education 

Association (ADEA) (2022 ADEA 

Healthy People 2030 Survey). 

8. EH–NEW–12: Reduce deaths related 

to heat. This objective is currently a 

development objective, EH–D02. Data 

source: National Vital Statistics 

System—Mortality. 

9. HOSCD–NEW–13: Increase the 

proportion of adults with 

communication disorders of voice, 

swallowing, speech, or language who 

have seen a health care specialist for 

evaluation or treatment in the past 12 

months. Data source: National Health 

Interview Survey (NHIS), CDC/NCHS. 

10. IID–NEW–18: Increase the 

proportion of pregnant women who 

receive 1 dose of the tetanus-diphtheriaacellular pertussis (Tdap) vaccine 

during pregnancy. Data source: National 

Health Interview Survey (NHIS), CDC/ 

NCHS. 

11. IID–NEW–19: Increase the 

proportion of adults who receive the 

recommended age-appropriate vaccine. 

Data source: National Health Interview 

Survey (NHIS), CDC/NCHS. 

12. MICH–NEW–21: Reduce the rate of 

hypertension in pregnancy (preexisting 

and pregnancy-associated hypertension) 

among delivery hospitalizations. Data 

source: Healthcare Cost and Utilization 

Project—National (Nationwide) 

Inpatient Sample (HCUP–NIS), Agency 

for Healthcare Research and Quality 

(AHRQ). 

The public also is invited to provide 

comment on the current Healthy People 

2030 objectives and propose additional 

core, developmental, or research 

objectives for consideration that address 

critical public health issues. Proposed 

new objectives must meet all the 

objective selection criteria (see below). 

The public is also invited to propose 

new topics to be considered for 

inclusion in Healthy People 2030. 

Objective Selection Criteria 

Core Objectives 

Core objectives must meet the 

following five criteria to be included in 

Healthy People 2030. Core objectives 

should (1) have a reliable, nationally 

representative data source with baseline 

data no older than 2015; (2) have at least 

two additional data points beyond the 

baseline during the decade; (3) be of 

national importance; (4) have effective, 

evidence-based interventions available 

to achieve the objective; and (5) have 

data to help address disparities and 

achieve health equity. 

Developmental Objectives 

Developmental objectives will have 

the following characteristics: (1) 

represent high priority issues; (2) do not 

have reliable baseline data yet; and (3) 

have evidence-based interventions 

available. 

Research Objectives 

Research objectives will have the 

following characteristics: (1) represent 

key opportunities to make progress in 

areas with limited prior research, a high 

health or economic burden, or 

significant disparities between 

population groups; (2) may or may not 

have reliable baseline data; and (3) do 

not have evidence-based interventions 

available. 

Written comments and evidencebased information should be submitted 

by email to HP2030Comment@hhs.gov 

by 11:59 p.m. ET on October 31, 2024. 

Comments received in response to this 

notice will be reviewed and considered 

by the Healthy People topic area 

workgroups, Federal Interagency 

Workgroup on Healthy People 2030, and 

other federal subject matter experts. 

Paul Reed, 

Deputy Assistant Secretary for Health, Office 

of Disease Prevention and Health Promotion. 

[FR Doc. 2024–22519 Filed 9–30–24; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Small Research Grants (R03) 

for New Investigators and Secondary Data 

Analysis PARs Review. 

Date: November 6–7, 2024. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research, 31 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Thomas John O’Farrell, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, National Institute of Dental and 

Craniofacial Research, 31 Center Drive, 

Bethesda, M.D. 20892, (301) 584–4859, email: 

tom.ofarrell@nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 


khammond on DSKJM1Z7X2PROD with NOTICES